Want to see CNTX full AI Analyst Report?
Context Therapeutics (CNTX) Ownership Overview
1.35%
Insiders
5.78% Mutual Funds
0.26% Other Institutional Investors
8.22% ETFs
84.40% Public Companies and
Individual Investors
The ownership structure of Context Therapeutics (CNTX) stock is a mix of institutional, retail, and individual investors. Approximately 14.25% of the company’s stock is owned by Institutional Investors, 1.35% is owned by Insiders, and 84.40% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $43097 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $90430 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,971,330 | Institution | 4.32% | 929,291 | |
| 3,439,626 | Institution | 3.74% | 804,872 | |
| 3,336,384 | Institution | 3.63% | 780,714 | |
| 2,440,330 | Institution | 2.66% | 571,037 | |
| 1,398,833 | Institution | 1.52% | 327,327 | |
| 1,079,891 | Insider | 1.18% | 252,694 | |
| 479,475 | Institution | 0.52% | 112,197 | |
| 163,527 | Institution | 0.18% | 38,265 | |
| 81,983 | Insider | 0.09% | 19,184 | |
| 80,010 | Insider | 0.09% | 18,722 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,336,384 | Institution | 3.63% | 780,714 | |
| 1,398,833 | Institution | 1.52% | 327,327 | |
| 479,475 | Institution | 0.52% | 112,197 | |
| 53,125 | Institution | 0.06% | 12,431 | |
| 42,444 | Institution | 0.05% | 9,932 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,815,486 | Institution | 3.06% | 845,772 | |
| 2,272,948 | Institution | 2.47% | 533,461 | |
| 881,593 | Institution | 0.96% | 206,910 | |
| 533,657 | Institution | 0.58% | 160,311 | |
| 520,997 | Institution | 0.57% | 156,508 | |
| 284,291 | Institution | 0.31% | 66,723 | |
| 101,016 | Institution | 0.11% | 30,345 | |
| 45,533 | Institution | 0.05% | 10,923 | |
| 9,876 | Institution | 0.01% | 2,369 | |
| 5,258 | Institution | <0.01% | 1,234 |
FAQ
Who Owns Context Therapeutics (CNTX)?
According to the latest TipRanks data, approximately 0.26% of the company's stock is held by institutional investors, 1.35% is held by insiders, and 84.40% is held by retail investors.
What percentage of Context Therapeutics (CNTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.26% of Context Therapeutics (CNTX) stock is held by institutional investors.
What percentage of Context Therapeutics (CNTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 84.40% of Context Therapeutics (CNTX) stock is held by retail investors.
Who owns the most shares of Context Therapeutics (CNTX)?
Vanguard owns the most shares of Context Therapeutics (CNTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.